Redirection of Care
Blue Cross Blue Shield of Wyoming is introducing a new redirection of care program for certain medications. When clinically appropriate services will be authorized in the most cost-effective setting, such as an Infusion Center, providers office, or via Home Health. If needed, BCBSWY will assist members with finding an appropriate site for care.
Please note, redirection of care does not affect your patient’s prescription drug benefits.
If a member is affected by this program, it will be noted in the authorization letter.
Who is Impacted:
As of January 1, 2022, the list below are the medications that will be subject to the redirection of care program for administration in the most cost-effective setting:
Neulasta | Remicade |
Avastin | Rituxab |
Herceptin | Keytruda |
Ocrevus | Opdivo |
Somatuline | Soliris |
This program will go into effect with new prescriptions or upon authorization renewal. Typically, medical authorizations expire one year from the date of the authorization.
Questions:
We have a Redirection of Care Team. If you’re currently taking one of these medications and have questions or concerns, please call 307-823-6095.
Upcoming Holiday Closures
BCBSWY will be closed on Friday, December 24 and Friday, December 31 in observance of the Christmas and New Year holiday.